United Pharmaceutical

Executive Summary

United Pharmaceutical is a privately held CDMO specializing in softgel encapsulation for the nutraceutical and dietary supplement markets. Founded in 2006 and headquartered in Fullerton, California, the company operates a 55,000-square-foot, climate-controlled facility providing end-to-end services from R&D and formulation to encapsulation, bottling, and labeling. As a U.S.-based manufacturer, it positions itself as a quality-focused partner for brands seeking domestic production to ensure supply chain reliability and regulatory compliance. The company serves a growing market driven by increasing consumer demand for dietary supplements and functional foods. While private with limited public financial data, its niche focus and established operations suggest steady revenue streams from contract manufacturing agreements. The absence of disclosed funding rounds or valuation implies a self-sustaining business model, likely generating stable cash flows from recurring client contracts.

Upcoming Catalysts (preview)

• Q3 2026Capacity expansion or new facility announcement60% success
• Q4 2026Strategic partnership with a major nutraceutical brand45% success
• TBDCertification for new production standards (e.g., organic or non-GMO)70% success